These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
663 related articles for article (PubMed ID: 25702227)
21. Neuroprotection and traumatic brain injury: theoretical option or realistic proposition. Faden AI Curr Opin Neurol; 2002 Dec; 15(6):707-12. PubMed ID: 12447109 [TBL] [Abstract][Full Text] [Related]
22. Modulation of traumatic brain injury using progesterone and the role of glial cells on its neuroprotective actions. Feeser VR; Loria RM J Neuroimmunol; 2011 Aug; 237(1-2):4-12. PubMed ID: 21777982 [TBL] [Abstract][Full Text] [Related]
24. Rosiglitazone exerts neuroprotective effects via the suppression of neuronal autophagy and apoptosis in the cortex following traumatic brain injury. Yao J; Zheng K; Zhang X Mol Med Rep; 2015 Nov; 12(5):6591-7. PubMed ID: 26351751 [TBL] [Abstract][Full Text] [Related]
25. Multifunctional drugs for head injury. Vink R; Nimmo AJ Neurotherapeutics; 2009 Jan; 6(1):28-42. PubMed ID: 19110197 [TBL] [Abstract][Full Text] [Related]
26. Function and Mechanisms of Autophagy in Brain and Spinal Cord Trauma. Lipinski MM; Wu J; Faden AI; Sarkar C Antioxid Redox Signal; 2015 Aug; 23(6):565-77. PubMed ID: 25808205 [TBL] [Abstract][Full Text] [Related]
27. Therapeutic targets for neuroprotection and/or enhancement of functional recovery following traumatic brain injury. Kelso ML; Pauly JR Prog Mol Biol Transl Sci; 2011; 98():85-131. PubMed ID: 21199771 [TBL] [Abstract][Full Text] [Related]
28. Drug therapies for stroke and traumatic brain injury often display U-shaped dose responses: occurrence, mechanisms, and clinical implications. Calabrese EJ Crit Rev Toxicol; 2008; 38(6):557-77. PubMed ID: 18615310 [TBL] [Abstract][Full Text] [Related]
29. Exogenous T3 administration provides neuroprotection in a murine model of traumatic brain injury. Crupi R; Paterniti I; Campolo M; Di Paola R; Cuzzocrea S; Esposito E Pharmacol Res; 2013 Apr; 70(1):80-9. PubMed ID: 23313345 [TBL] [Abstract][Full Text] [Related]
30. Cannabinoids as neuroprotective agents in traumatic brain injury. Biegon A Curr Pharm Des; 2004; 10(18):2177-83. PubMed ID: 15281893 [TBL] [Abstract][Full Text] [Related]
31. A review of neuroprotection pharmacology and therapies in patients with acute traumatic brain injury. McConeghy KW; Hatton J; Hughes L; Cook AM CNS Drugs; 2012 Jul; 26(7):613-36. PubMed ID: 22668124 [TBL] [Abstract][Full Text] [Related]
33. Medical treatment and neuroprotection in traumatic brain injury. Clausen T; Bullock R Curr Pharm Des; 2001 Oct; 7(15):1517-32. PubMed ID: 11562296 [TBL] [Abstract][Full Text] [Related]
34. Current understanding of neuroinflammation after traumatic brain injury and cell-based therapeutic opportunities. Xiong Y; Mahmood A; Chopp M Chin J Traumatol; 2018 Jun; 21(3):137-151. PubMed ID: 29764704 [TBL] [Abstract][Full Text] [Related]
35. The Role of Estradiol in Traumatic Brain Injury: Mechanism and Treatment Potential. Kövesdi E; Szabó-Meleg E; Abrahám IM Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374952 [TBL] [Abstract][Full Text] [Related]
36. Progesterone as a neuroprotective factor in traumatic and ischemic brain injury. Sayeed I; Stein DG Prog Brain Res; 2009; 175():219-37. PubMed ID: 19660659 [TBL] [Abstract][Full Text] [Related]
37. The role of mitochondrial calcium uniporter in neuroprotection in traumatic brain injury. Cheng G; Fu L; Zhang HY; Wang YM; Zhang LM; Zhang JN Med Hypotheses; 2013 Feb; 80(2):115-7. PubMed ID: 23200456 [TBL] [Abstract][Full Text] [Related]
38. A clinical/translational perspective: can a developmental hormone play a role in the treatment of traumatic brain injury? Stein DG Horm Behav; 2013 Feb; 63(2):291-300. PubMed ID: 22626570 [TBL] [Abstract][Full Text] [Related]